|
(PQ 9) Dysregulation of epidermal MMP-13 as cause of paclitaxel-induced peripheral neuropathy
|
1R01CA215973-01
|
$443,022
|
RIEGER, SANDRA
|
MOUNT DESERT ISLAND BIOLOGICAL LAB
|
|
(PQ#9): Altered mitochondrial transport and chemotherapy-induced peripheral neuropathy
|
1R21CA215985-01
|
$198,000
|
CHANG, KAREN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
(PQ9) A NOVEL MECHANISM OF PACLITAXEL-INDUCED PERIPHERAL NEUROPATHY AND POTENTIAL TREATMENT
|
7R01CA208765-02
|
$356,362
|
YANG, QING
|
UNIVERSITY OF TEXAS MED BR GALVESTON
|
|
(PQ9) Mitigation of chemotherapy induced peripheral neuropathy
|
5R01CA206028-02
|
$342,964
|
GEWIRTZ, DAVID
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
(PQ9) The role of Bclw (bcl2l2) in preventing chemotherapy induced neuropathy
|
5R01CA205255-02
|
$577,463
|
SEGAL, ROSALIND
|
DANA-FARBER CANCER INST
|
|
(PQD2)New Biomarkers and Pathways to Enhance Cure in Ovarian Cancers
|
5R01CA184968-04
|
$509,161
|
SIKIC, BRANIMIR
|
STANFORD UNIVERSITY
|
|
. Methylation and silencing of human p15INK4b in acute myeloid leukemia
|
Z01 BC 011034
|
$255,080
|
Wolff, Linda
|
CCR (NCI)
|
|
A biophysical approach to elucidating the molecular mechanisms of mitotic inhibitor targets
|
1F99CA223018-01
|
$32,868
|
MICKOLAJCZYK, KEITH
|
PENNSYLVANIA STATE UNIVERSITY-UNIV PARK
|
|
A cohort study among workers exposed to benzene in China
|
Z01 CP010120-02060
|
$1,557,754
|
Hayes, Richard
|
DCEG (NCI)
|
|
A collaborative case-control study of childhood leukemia and EMF and radon exposu
|
Z01 CP010135-04040
|
$19,922
|
Inskip, Peter
|
DCEG (NCI)
|
|
A computer aided chromosome imaging technique for cancer diagnosis
|
5R01CA115320-03
|
$312,688
|
Liu, Hong
|
UNIVERSITY OF OKLAHOMA NORMAN
|
|
A CROSS-SECTIONAL STUDY OF OCCUPATIONAL EXPOSURE TO TRICHLOROETHYLENE, CHROMOSOMA
|
Z01 CP010121-10363
|
$64,805
|
Rothman, Nathaniel
|
DCEG (NCI)
|
|
A NOVEL MECHANISM OF TCL1 TUMORIGENESIS
|
5R01CA107300-05
|
$270,281
|
TEITELL, MICHAEL
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
A Novel Oncogenic Role for Cdc20 Implications in Adult T Cell Leukemia Treatment
|
5R00CA183914-04
|
$254,171
|
WAN, LIXIN
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
A Novel Strategy for Defining and Targeting Cancer Addiction to Anti-Apoptotic BC
|
5R01CA129974-02
|
$324,900
|
LETAI, ANTHONY
|
DANA-FARBER CANCER INSTITUTE
|
|
A Pathway-based approach to investigate oncogenic mechanisms in ovarian cancer
|
5R00CA166228-05
|
$249,000
|
GATZA, MICHAEL
|
RBHS -CANCER INSTITUTE OF NEW JERSEY
|
|
A pilot study of lung cancer and hematopoietic malignancy in the Guangzhou, China
|
Z01 CP010120-10365
|
$31,369
|
Hayes, Richard
|
DCEG (NCI)
|
|
A Role for KSHV in the Pathogenesis of Malignancies
|
Z01 SC 010356
|
$365,279
|
Tosato, Giovanna
|
CCR (NCI)
|
|
A Role for PML in Genome Stability and DNA Damage Response
|
5R01CA055577-15
|
$264,061
|
CHANG, KUN-SANG
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
A3AR agonists to prevent chemotherapy-induced painful peripheral neuropathy
|
5R01CA169519-05
|
$311,250
|
SALVEMINI, DANIELA
|
SAINT LOUIS UNIVERSITY
|
|
AARP prospective study of diet and cancer
|
Z01 CP010196-03152
|
$2,416,410
|
Schatzkin, Arthur
|
DCEG (NCI)
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
3P30CA016520-33S1
|
$104,604
|
Thompson, Craig
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
3P30CA016520-33S2
|
$250,000
|
Thompson, Craig
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
5P30CA016520-33
|
$7,326,647
|
Thompson, Craig
|
UNIVERSITY OF PENNSYLVANIA
|
|
Activation of Proto-Oncogenes by Chromosomal Translocation
|
Z01 SC 010378
|
$258,071
|
Aplan, Peter
|
CCR (NCI)
|
|
Adenosine Analogs: Therapeutics for Hematologic Cancers
|
3R01CA085915-08S1
|
$51,498
|
ROSEN, STEVEN
|
NORTHWESTERN UNIVERSITY
|
|
Adenosine Analogs: Therapeutics for Hematologic Cancers
|
5R01CA085915-08
|
$311,663
|
ROSEN, STEVEN
|
NORTHWESTERN UNIVERSITY
|
|
Adoptive immunotherapy after umbilical cord blood transplant
|
5R01CA124782-02
|
$292,600
|
COOPER, LAURENCE
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Adult Leukemia Research Center
|
3P01CA018029-33S1
|
$140,652
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Adult Leukemia Research Center
|
5P01CA018029-33
|
$4,943,916
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
ADVANCED TECHNOLOGY FOR ASSAYING CANCER-DRUG RESISTANCE
|
2R44CA114126-02
|
$419,983
|
Lim, Mark
|
AMBERGEN, INC
|
|
ALARA Meeting
|
Z01 CP010131-10444
|
$19,805
|
Ron, Elaine
|
DCEG (NCI)
|
|
ALL Fusion Proteins: Associated with Multi-protein Complexes and Role in Transcri
|
5R01CA128609-03
|
$300,246
|
CROCE, CARLO
|
OHIO STATE UNIVERSITY
|
|
Alternative Entry Mechanism for Pathogenic Retroviruses
|
5R01CA104266-05
|
$259,594
|
CUNNINGHAM, JAMES
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Analysis of a murine model of the AML1-ETO translocation
|
5R01CA096798-05
|
$281,848
|
KLUG, CHRISTOPHER
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Analysis of Blood Borne Markers in Hormone Sensitive Metastatic Prostate Cancer
|
5R01CA208254-02
|
$481,793
|
SWEENEY, CHRISTOPHER
|
DANA-FARBER CANCER INST
|
|
Analysis of Intracellular Drug Sequestration
|
5R01CA106655-04
|
$205,489
|
KRISE, JEFFREY
|
UNIVERSITY OF KANSAS LAWRENCE
|
|
Anatomic Pathology Residency Program
|
Z01 BC 010684
|
$1,300,000
|
Jaffe, Elaine
|
CCR (NCI)
|
|
Animal models to study the role of INK4b loss in human acute myeloid leukemia
|
Z01 BC 011027
|
$510,160
|
Wolff, Linda
|
CCR (NCI)
|
|
Anti-CCL25 mAb to treat castration resistant prostate cancer
|
1R41CA214080-01
|
$350,000
|
SINGH, SHAILESH
|
JYANT, INC.
|
|
Antibody Engineering for Therapy and Diagnosis of Hematologic Malignancies
|
Z01 BC 010647
|
$410,318
|
Rader, Christoph
|
CCR (NCI)
|
|
Antibody V Gene Expression B Cell Lymphocytic Leukemia
|
5R37CA049870-21
|
$329,612
|
KIPPS, THOMAS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Antigen Presenting Cells in the Induction of GVHD
|
7R01CA102464-05
|
$234,707
|
ZHANG, YI
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Antileukemic effort of NK cells in HCT for pediatric AML
|
5R01CA120583-02
|
$364,712
|
LEUNG, WING
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Antitumor-Antibiotics from Marine Microorganisms
|
5R37CA044848-22
|
$360,308
|
FENICAL, WILLIAM
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
AP-1 Complexes and Target Gene Regulation
|
5R01CA114381-03
|
$256,204
|
TAPAROWSKY, ELIZABETH
|
PURDUE UNIVERSITY WEST LAFAYETTE
|
|
Aptamer Based Technology for Molecular Analysis of Leukemia
|
1R01CA129311-01A2
|
$303,988
|
Li, Ying
|
UNIVERSITY OF FLORIDA
|
|
Arsenic Trioxide Activaed Pathways in APL
|
5R01CA121192-03
|
$260,253
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY
|
|
Arsenic Trioxide and Acute Myeloid Leukemia
|
2R01CA093533-05A1
|
$255,079
|
JING, YONGKUI
|
MOUNT SINAI SCHOOL OF MEDICINE OF NYU
|
|
Arsenic Trioxide in Primary Curative APL Therapy
|
5R01CA100904-05
|
$420,352
|
GORE, STEVEN
|
JOHNS HOPKINS UNIVERSITY
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|